Holen Sie sich die Stockscreener-App
2.21
1.34%
-0.03
Handel nachbörslich:
2.21
Schlusskurs vom Vortag:
$2.24
Offen:
$2.23
24-Stunden-Volumen:
39,935
Relative Volume:
0.36
Marktkapitalisierung:
$28.10M
Einnahmen:
$10.96M
Nettoeinkommen (Verlust:
$-7.02M
KGV:
-3.4531
EPS:
-0.64
Netto-Cashflow:
$-3.72M
1W Leistung:
+27.75%
1M Leistung:
+50.34%
6M Leistung:
-44.82%
1J Leistung:
-53.81%
1-Tages-Spanne:
$2.03
$2.23
1-Wochen-Bereich:
$1.6976
$2.28
52-Wochen-Spanne:
$1.31
$5.45
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Firmenname
Collplant Biotechnologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.21 | 22.00M | 10.96M | -7.02M | -3.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-17 | Eingeleitet | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
What drives CollPlant Biotechnologies Ltd. stock priceHigh-yield investments - jammulinksnews.com
What analysts say about CollPlant Biotechnologies Ltd. stockDynamic portfolio growth - Autocar Professional
What makes CollPlant Biotechnologies Ltd. stock price move sharplyTop ROI Selections - Newser
Is CollPlant Biotechnologies Ltd. a good long term investmentExponential wealth increase - jammulinksnews.com
CollPlant Biotechnologies Ltd. Stock Analysis and ForecastTremendous return rates - jammulinksnews.com
How CollPlant Biotechnologies Ltd. stock performs during market volatilityFree Predictions - Newser
Brown Advisory Inc. Sells 8,265 Shares of CollPlant Biotechnologies Ltd. Sponsored ADR (NASDAQ:CLGN) - Defense World
Tissue Engineering Market Attracts Investment in Stem Cell - openPR.com
Why CollPlant Biotechnologies Ltd. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser
CollPlant names new VP to lead North American commercial operations - Investing.com Australia
COLLPLANT BIOTECHNOLOGIESNEW Earnings Preview: Recent $CLGN Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Collplant Biotechnologies Ltd expected to post a loss of 14 cents a shareEarnings Preview - TradingView
CLGN 6-K: CollPlant Announces New North America Commercial Head | MS SEC FilingForm 424B2 - Stock Titan
CLGN 6-K: CollPlant Announces New North America Commercial Head | CLGN SEC FilingForm 6-K - Stock Titan
CollPlant names new VP to lead North American commercial operations By Investing.com - Investing.com South Africa
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations - Financial Times
CollPlant Accelerates US Expansion: Biotech Veteran to Scale rhCollagen Platform Development - Stock Titan
CollPlant Biotechnologies (NASDAQ:CLGN) Trading Up 2.1% – Should You Buy? - Defense World
CollPlant Biotechnologies shares slide after announces capital raise of $3.6M through registered direct offering - MSN
Is CollPlant Biotechnologies Ltd. overvalued or undervalued? - MarketsMojo
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative - Barchart.com
CollPlant shares rise on expanded partnership with STEMCELL Technologies - MSN
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES - marketscreener.com
CollPlant (CLGN) Expands Partnership with STEMCELL Technologies - GuruFocus
CollPlant Biotechnologies (CLGN) Shares Surge on Expanded STEMCE - GuruFocus
CollPlant's Plant-Based Collagen Advances to Clinical Applications in Major STEMCELL Technologies Deal - Stock Titan
CollPlant secures European patent for collagen products By Investing.com - Investing.com South Africa
CollPlant Biotechnologies Announces European Patent Acceptance Secured for Its Collaboration Multiple as Soft Tissue Fillers and Implants - marketscreener.com
CollPlant secures European patent for collagen products - Investing.com Australia
CollPlant (CLGN) Secures European Patent for Injectable Fillers and Implants | CLGN Stock News - GuruFocus
Finanzdaten der Collplant Biotechnologies Ltd-Aktie (CLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):